[Association Between Parkinson's Disease and Functionality in Older Adults in Chile: The Case of the Maipú Commune].

Rev Med Chil

Núcleo de Envejecimiento de la Unidad de Nutrición Pública, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago, Chile.

Published: July 2024

Unlabelled: Population aging has caused a rise in neurodegenerative diseases among which includes Parkinson's disease. However, in Chile, there is still little knowledge about how Parkinson's disease is associated with functionality in elderly people.

Aim: to examine the association between Parkinson's disease and functionality in elderly people of Maipú, Metropolitan region, between the years 2017-2019.

Methods: A quantitative study with an observational design was conducted. A sample of 4.843 elderly people (≥65 years) enrolled in CESFAM Michelle Bachelet in Maipú was used. To examine the association between Parkinson's disease and functionality, we use logistic regression models adjusted by demographic, socioeconomic, and health variables.

Results: People with Parkinson's disease are 3.3 times more likely to experience functional limitation (p-value<0.001). At the same time, males (OR= 1.3; 95% CI 1,1-1,5; p-value<0.001), of old age (OR= 10; 95% CI 7,9-12,6; p-value<0.001, on people 85 years old) with low schooling (OR= 1,7) and belonging to A-B segment of FONASA (OR= 1,3) have more chances of having functional limitations.

Conclusion: The study shows a significant association between Parkinson's disease and functional limitations, supported by the literature. Although this study accounts for the specific reality of a territory, its results can be useful in designing strategies and interventions that could help improve the quality of life of people with Parkinson's disease and their families in other urban territories of the country.

Download full-text PDF

Source
http://dx.doi.org/10.4067/s0034-98872024000700759DOI Listing

Publication Analysis

Top Keywords

parkinson's disease
24
disease functionality
12
functionality elderly
8
examine association
8
association parkinson's
8
elderly people
8
disease
6
parkinson's
5
[association parkinson's
4
functionality
4

Similar Publications

Searching for new drugs to treat Alzheimer's disease dementia through multiple pathways.

World J Clin Cases

January 2025

Department of Neurology, Guizhou Medical University, Guiyang 550004, Guizhou Province, China.

Dementia is a group of diseases, including Alzheimer's disease (AD), vascular dementia, Lewy body dementia, frontotemporal dementia, Parkinson's disease dementia, metabolic dementia and toxic dementia. The treatment of dementia mainly includes symptomatic treatment by controlling the primary disease and accompanying symptoms, nutritional support therapy for repairing nerve cells, psychological auxiliary treatment, and treatment that improves cognitive function through drugs. Among them, drug therapy to improve cognitive function is important.

View Article and Find Full Text PDF

This study aimed to evaluate different combinations of three dietary supplements for potential additive or synergistic effects in an Parkinson's Disease model. The complex and diverse processes leading to neurodegeneration in each patient with a neurodegenerative disorder cannot be effectively addressed by a single medication. Instead, various combinations of potentially neuroprotective agents targeting different disease mechanisms simultaneously may show improved additive or synergistic efficacy in slowing the disease progression and allowing the agents to be utilized at lower doses to minimize side effects.

View Article and Find Full Text PDF

Targeting cardiolipin metabolism for Parkinson's disease therapy.

Metabol Open

December 2024

Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias, Goudi, 11527, Athens, Greece.

View Article and Find Full Text PDF

Parkinson's disease (PD) is a neurodegenerative disorder that significantly impacts patients' quality of life. Managing PD requires accurate assessment of motor and non-motor symptoms, often complicated by the subjectivity in symptom reporting and the limited availability of neurologists. To address these challenges, commercial wearable devices have emerged to continuously monitor PD symptoms outside the clinical setting.

View Article and Find Full Text PDF

Background: Interest in wearable device use in Parkinson's disease (PD) has grown rapidly with many compelling studies supporting diagnostic and therapeutic uses. Concurrently, consumer devices have proliferated and their role in health and wellness has expanded. However, incorporation of consumer and medical wearable devices into medical care has in our experience been limited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!